NCT07290309 Survivors Uniting for Remote Guided Exercise
| NCT ID | NCT07290309 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Colorado State University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-02-06 |
| Primary Completion | 2029-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2026-02-06 with a primary completion date of 2029-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to look at how live, online group exercise compares to recorded videos for helping increase physical activity levels, improve physical fitness and quality of life, and reduce loneliness among those living with and beyond cancer. The following aims have been established for this study: * Aim 1: Examine the effect of a group-based videoconference physical activity (PA) intervention on moderate to vigorous physical activity \[MVPA\] (i.e., aerobic and resistance exercise). * Aim 2: Examine the effect of the intervention on additional health-related outcomes including physical fitness (i.e., aerobic endurance, muscular strength), and quality of life at both timepoints. * Aim 3: Explore potential mediators and moderators of intervention effects. We will examine mediators (e.g., self-efficacy, outcome expectations, group cohesion) and moderators (e.g., age, cancer stage, neighborhood walkability) of the intervention on MVPA. * Exploratory Aim: Determine whether a group-based videoconference PA intervention reduces loneliness among cancer survivors. Researchers will randomize participants into one of two guided exercise groups that are 12-weeks long in duration. Participants will be asked to complete online fitness assessments and surveys as well as wear a physical activity monitor device and watch a few times throughout the study. The whole study is 9-months long in duration with a 6-month free-living period where no study activities will take place.
Eligibility Criteria
Inclusion Criteria: * Able to speak/read English, * Diagnosed with any type of cancer within the last 5 years * Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy, immunotherapies) Exclusion Criteria: * Existing participation in ≥150 minutes per week of at least moderate intensity aerobic exercise * Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device) * Current or planned participation in another structured program or intervention intended to encourage participation in exercise or physical activity.
Contact & Investigator
Heather J Leach, PhD
PRINCIPAL INVESTIGATOR
Colorado State University
Frequently Asked Questions
Who can join the NCT07290309 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07290309 currently recruiting?
Yes, NCT07290309 is actively recruiting participants. Contact the research team at heather.leach@colostate.edu for enrollment information.
Where is the NCT07290309 trial being conducted?
This trial is being conducted at Fort Collins, United States.
Who is sponsoring the NCT07290309 clinical trial?
NCT07290309 is sponsored by Colorado State University. The principal investigator is Heather J Leach, PhD at Colorado State University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.